CTLA‐4 polymorphism contributes to the genetic susceptibility of epithelial ovarian cancer

Cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4), an inhibitory molecule on T‐cells, plays a key role in tumorigenesis and progression. In the present study, we investigated the effects of three polymorphisms in the CTLA‐4 gene on the risk of epithelial ovarian cancer and the clinical outcomes of patients.

• Publication year

  2022

• Venue

  The journal of obstetrics and gynaecology research

• Publication date

  2022-02-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/jog.15186PMID 35150042
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CTLA-4 rs5742909 polymorphism and cervical cancer risk

  2020cited by this paper
• CTLA-4 polymorphisms and predisposition to digestive system malignancies: a meta-analysis of 31 published studies

  2020cited by this paper
• Association between CYP1A1 rs4646903 T > C genetic variations and male infertility risk

  2019cited by this paper
• Cancer incidence and mortality

  2019cited by this paper
• Association of cytotoxic T‐lymphocyte associated protein 4 gene polymorphisms with the risk and prognosis of oesophageal cancer in a high‐incidence region from northern China

  2019cited by this paper
• Cancer incidence and mortality in China, 2014.

  2018cited by this paper
• Overcoming Tumor-Induced Immune Suppression: From Relieving Inhibition to Providing Costimulation with T Cell Agonists

  2018cited by this paper
• miRNAs and ovarian cancer: An overview

  2018cited by this paper
• What did we learn from CTLA‐4 insufficiency on the human immune system?

  2018cited by this paper
• Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies

  2018cited by this paper
• Investigation of Cytotoxic T-lymphocyte antigen-4 polymorphisms in non-small cell lung cancer: a case-control study

  2017cited by this paper
• CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor

  2016cited by this paper
• Investigation of Cytotoxic T‐lymphocyte antigen 4 Polymorphisms in Gastric Cardia Adenocarcinoma

  2016cited by this paper
• Lack of association between cytotoxic T-lymphocyte antigen-4 gene polymorphisms and lymphoid malignancy risk: evidence from a meta-analysis

  2016cited by this paper
• Association of CTLA4 and CD28 Gene Variants and Circulating Levels of Their Proteins in Patients with Breast Cancer.

  2016cited by this paper
• Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1.

  2015cited by this paper
• Associations between CTLA-4 +49 A/G (rs231775) polymorphism and cancer risk: a meta-analysis based on 52 case-control studies.

  2015cited by this paper
• Polymorphisms of co-inhibitory molecules (CTLA-4/PD-1/PD-L1) and the risk of non-small cell lung cancer in a Chinese population.

  2015cited by this paper
• Comprehensive Evaluation of the Cytotoxic T-Lymphocyte Antigen-4 Gene Polymorphisms in Risk of Bone Sarcoma

  2014cited by this paper
• Quality of information and cancer care planning in China: a commentary to the report of cancer incidence and mortality in China.

  2014cited by this paper
• Association of CTLA-4 gene polymorphisms with sporadic breast cancer risk and clinical features in Han women of Northeast China

  2012cited by this paper
• The functional cytotoxic T lymphocyte–associated Protein 4 49G‐to‐A genetic variant and risk of pancreatic cancer

  2012cited by this paper
• CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.

  2011cited by this paper
• CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers-hepatocellular carcinoma and cervical cancer.

  2010cited by this paper
• Ovarian cancer: an overview.

  2009cited by this paper
• Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer.

  2008cited by this paper
• Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population

  2007cited by this paper
• Genetic analysis and functional evaluation of the C/T(-318) and A/G(-1661) polymorphisms of the CTLA-4 gene in patients affected with Graves' disease.

  2006cited by this paper
• Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer

  2005cited by this paper
• A Common Autoimmunity Predisposing Signal Peptide Variant of the Cytotoxic T-lymphocyte Antigen 4 Results in Inefficient Glycosylation of the Susceptibility Allele*

  2002cited by this paper
• CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms

  2001cited by this paper
• CD28 Costimulation Mediates T Cell Expansion Via IL-2-Independent and IL-2-Dependent Regulation of Cell Cycle Progression1

  2000cited by this paper
• CTLA-4 can function as a negative regulator of T cell activation.

  1994cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper

• Negative Immune Checkpoint Inhibitors

  2025cites this paper
• Recent advances in understanding the immune microenvironment in ovarian cancer

  2024cites this paper
• Current Understanding on Why Ovarian Cancer Is Resistant to Immune Checkpoint Inhibitors

  2023influential citation
• Epithelial Ovarian Cancer: Microenvironment and Immunecheck Point Inhibitors

  2023cites this paper
• Advances in ligase-based nucleic acid amplification technology for detecting gene mutations: a review

  2022cites this paper